3 Hematology Headlines You Missed in July 2026

Hematology in July 2026: FDA priority review for Agios' mitapivat in sickle cell disease, plus Orca-T's approval for GVHD-free survival.

July included regulatory movement in sickle cell disease and a discontinued development program in the same condition.